Several studies have discovered the pharmaceutical advancement in one or several features of BV, primarily focusing on pain-relieving (Lee et al., 2005), neuroprotective (Ye et al., 2016b), anti-inflammation (Jeong et al., 2017), enhancing wound recovery (Hozzein et al., 2018), anti-microbial impacts (El-Seedi et al., 2020), and cancer-fighting (Maek et al., 2023)
Beyond weight loss: a case study and narrative review of the potential role of glucagon-like peptide-1 receptor agonists for the treatment of idiopathic intracranial hypertension Introduction Idiopathic intracranial hypertension (IIH), or pseudotumor cerebri, is a disorder characterized by elevated intracranial pressure (ICP) with no identifiable structural cause, such as a mass lesion or obstructive hydrocephalus
10.1017/S0007114511001152 125
200 KimO-KJunWLeeJ
However, in an effort to reach a wider market of consumers, the team has launched a company called Satisfed and is seeking partners in the industry capable of scaling production to thousands of tons
61 WP is a rich source of glutamine and researchers have shown that WP supplementation is capable of reducing intestinal permeability